Results 151 to 160 of about 36,320 (224)

Transitioning Prostacyclin Pathway Agents to Oral Selexipag in Patients with Pulmonary Arterial Hypertension: A Systematic Literature Review. [PDF]

Adv Ther
Elwing JM, Krishnan M, Parikh KS, Sargent T, Wu S, Benninger C, Doad G, Hill W, Oswald C, Bridge DC, O'Donovan P, Maranes LV, Miller C.   +12 more
europepmc   +1 more source

Advances in and Clinical Experience with Subcutaneous Infusion Pump Therapy for Pulmonary Arterial Hypertension. [PDF]

Adv Ther
LaRoy V, Roberts E, Mayeux J, Patzlaff N, Ismail R, Roberts K, Reed L, Stewart T, Whittenhall M, Wilson M.   +9 more
europepmc   +1 more source

Association of Pericardial Tamponade With Initiation of Sotatercept in a Patient With Eisenmenger Syndrome. [PDF]

Pulm Circ
Aldawsari KA, Simpkin CT, Frank BS, Ivy DD.   +3 more
europepmc   +1 more source

Beraprost Attenuates Starvation-Induced Apoptosis and Protects Feline Endothelial Cells. [PDF]

Vet Med Sci
Matsuura T, Marasigan CNBB, Yonezawa T.
europepmc   +1 more source

The Clinical and Economic Burden of Pulmonary Arterial Hypertension in Israel, 2014-2022: A Retrospective Analysis of Healthcare Costs and Utilization. [PDF]

Pulm Circ
Saciuk Y, Mamane C, Patalon T, Lévy-Bachelot L, Hoshen M, Moser SS, Shafran I, Safwat M, Adir Y, Numa R, Ben-Dayan E, Gazit S, Segel MJ.   +12 more
europepmc   +1 more source

Clinical Updates in Pulmonary Hypertension. [PDF]

Rev Cardiovasc Med
Diaz G, Lawrence A, Ossi J, Arungwa D, Weiss A, Virk HUH, Khawaja M, Krittanawong C.   +7 more
europepmc   +1 more source

Use of Sotatercept to Facilitate Transition From Intravenous to Oral Prostacyclin Therapy. [PDF]

Clin Respir J
Dagher C, Akiki M, Swanson K, Carollo B, Chernobelsky E, Farber HW, Parikh R.   +6 more
europepmc   +1 more source

Early Results of Sotatercept Treatment in Patients With Severe Pulmonary Hypertension and a Potts Shunt. [PDF]

Pulm Circ
Aggarwal MA, Merrill K, Yung D, Mark Grady R.   +3 more
europepmc   +1 more source